Five Prime Therapeutics, Inc. Pre-Tax Profit Margin 2013-2020 | FPRX
Five Prime Therapeutics, Inc. pre-tax profit margin from 2013 to 2020. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
Pre-Tax Profit Margin Historical Data |
Date |
TTM Revenue |
TTM Pre-Tax Income |
Pre-Tax Margin |
2020-12-31 |
$0.01B |
$-0.09B |
-758.33% |
2020-09-30 |
$0.02B |
$-0.10B |
-631.25% |
2020-06-30 |
$0.02B |
$-0.10B |
-611.76% |
2020-03-31 |
$0.02B |
$-0.12B |
-711.76% |
2019-12-31 |
$0.01B |
$-0.14B |
-971.43% |
2019-09-30 |
$0.02B |
$-0.14B |
-960.00% |
2019-06-30 |
$0.02B |
$-0.16B |
-861.11% |
2019-03-31 |
$0.02B |
$-0.16B |
-673.91% |
2018-12-31 |
$0.05B |
$-0.14B |
-280.00% |
2018-09-30 |
$0.06B |
$-0.13B |
-220.34% |
2018-06-30 |
$0.06B |
$-0.13B |
-206.56% |
2018-03-31 |
$0.06B |
$-0.14B |
-221.31% |
2017-12-31 |
$0.04B |
$-0.15B |
-379.49% |
2017-09-30 |
$0.03B |
$-0.15B |
-441.18% |
2017-06-30 |
$0.03B |
$-0.13B |
-403.03% |
2017-03-31 |
$0.03B |
$-0.11B |
-323.53% |
2016-12-31 |
$0.03B |
$-0.10B |
-312.90% |
2016-09-30 |
$0.39B |
$0.27B |
69.43% |
2016-06-30 |
$0.39B |
$0.27B |
70.13% |
2016-03-31 |
$0.38B |
$0.28B |
73.04% |
2015-12-31 |
$0.38B |
$0.29B |
75.99% |
2015-09-30 |
$0.02B |
$-0.06B |
-276.19% |
2015-06-30 |
$0.02B |
$-0.04B |
-195.24% |
2015-03-31 |
$0.02B |
$-0.04B |
-200.00% |
2014-12-31 |
$0.02B |
$-0.04B |
-190.00% |
2014-09-30 |
$0.02B |
$-0.03B |
-173.68% |
2014-06-30 |
$0.02B |
$-0.03B |
-206.25% |
2014-03-31 |
$0.02B |
$-0.03B |
-200.00% |
2013-12-31 |
$0.01B |
$-0.03B |
-200.00% |
2013-09-30 |
$0.01B |
$-0.03B |
-207.69% |